Core Viewpoint - Precision Optics Corporation has announced the pricing of its public offering of 2,777,777 shares at $3.60 per share, indicating strong interest from both existing and new institutional investors [1][2]. Group 1: Offering Details - The offering was oversubscribed and included participation from company executives, such as the President and CEO, who purchased shares at the public offering price [2]. - Lucid Capital Markets is the sole book-running manager for the offering, which is expected to close on or about March 30, 2026, subject to customary closing conditions [3]. - The company has granted the underwriter a 45-day option to purchase an additional 416,667 shares at the public offering price [3]. Group 2: Use of Proceeds - The net proceeds from the offering will be used for working capital and general corporate purposes [4]. Group 3: Company Overview - Precision Optics Corporation, founded in 1982, specializes in advanced optical instruments for the medical and defense/aerospace industries, leveraging proprietary technologies [7]. - The company provides services from product concept to mass manufacture, focusing on next-generation medical devices and defense applications [7].

Company Overview - Precision Optics Corporation, Inc. is a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, founded in 1982 [5] - The company focuses on leveraging proprietary micro-optics, 3D imaging, and digital imaging technologies to meet the demands of healthcare and defense/aerospace sectors [5] - Precision Optics provides services ranging from new product concept through mass manufacture, utilizing in-house design, prototype, regulatory, and fabrication capabilities [5] Public Offering Announcement - Precision Optics Corporation has announced the commencement of an underwritten public offering of shares of its common stock, subject to market conditions [1] - Lucid Capital Markets is acting as the sole book-running manager for the offering, which is made pursuant to a shelf registration statement filed with the SEC [2] - A preliminary prospectus supplement and accompanying prospectus will be filed with the SEC and made available on the SEC's website [3]

Core Viewpoint - Precision Optics Corporation reported record revenue of $7.4 million for Q2 FY 2026, reflecting a 63% increase year-over-year, driven by strong demand in its core production programs and significant growth in its aerospace and single-use cystoscope programs [3][6]. Financial Highlights - Q2 FY 2026 revenues reached $7,369,837, compared to $4,526,907 in Q2 FY 2025, marking a 63% increase [5][6]. - Production revenue was $6.4 million, a 105% increase from $3.1 million in the same quarter of the previous fiscal year [6]. - Engineering revenue decreased to $1.0 million from $1.4 million year-over-year, a decline of 29% [6]. - Gross profit for Q2 FY 2026 was $204,660, with gross margins at 2.8%, down from 23.6% in the same quarter of the previous fiscal year [6][7]. - The net loss for the quarter was $(1.8) million, compared to $(1.0) million in Q2 FY 2025 [6][7]. Future Guidance - The company projects FY 2026 revenue to be between $26 million and $28 million, indicating a growth of 36% to 47% over FY 2025 [6]. - Adjusted EBITDA for FY 2026 is expected to be approximately $(2.5) to $(3.0) million, an improvement from $(3.7) million in FY 2025 [6]. Operational Insights - The company is investing in infrastructure to enhance production efficiency and is seeing operational improvements under new leadership [4]. - Product Development bookings have increased for three consecutive quarters, reaching their highest level in over a year [4]. - The Ross Optical division is entering Q3 with its strongest backlog in more than three years, positioning the company for profitable growth [4].

Core Viewpoint - Precision Optics Corporation is set to announce its second quarter fiscal year 2026 financial results on February 17, 2026, followed by a conference call to discuss these results [1][2]. Company Overview - Precision Optics Corporation, founded in 1982, specializes in advanced optical instruments for the medical and defense/aerospace industries, leveraging proprietary technologies in micro-optics, 3D imaging, and digital imaging [5]. - The company provides comprehensive services from product concept to mass manufacturing, utilizing in-house design, regulatory, and fabrication capabilities [5]. - In the healthcare sector, Precision Optics supports the development of enhanced imaging systems for minimally invasive surgeries and 3D endoscopy systems, catering to the growing demands of the surgical community [5]. - The company also applies its micro-optics expertise to defense/aerospace applications, focusing on high-quality standards and optimization of size, weight, and power [5]. Conference Call Details - The conference call is scheduled for February 17, 2026, at 5:00 p.m. ET, with access available via phone or live webcast [3]. - Call-in numbers include (844) 735-3662 or (412) 317-5705, and the webcast can be accessed at https://app.webinar.net/Zo5aLdzPzmg [3]. - A replay of the call will be available for seven days, with specific numbers and access codes provided for teleconference and webcast replays [4].

Core Viewpoint - Precision Optics Corporation reported record quarterly revenue of $6.7 million for Q1 FY 2026, a 59% increase year-over-year, driven by multi-year agreements with aerospace and surgical robotics companies [4][5]. Financial Highlights - Revenue for Q1 FY 2026 was $6.7 million, up from $4.2 million in the same quarter of the previous fiscal year, representing a growth of approximately 59% [5]. - Production revenue reached $6.0 million, a 133% increase from $2.6 million in the same quarter of the previous fiscal year [5]. - Engineering revenue decreased to $0.7 million from $1.6 million, a decline of 59% [5]. - Gross margins were 14.2%, down from 26.6% in the same quarter of the previous fiscal year [5]. - The net loss for the quarter was $(1.6) million, compared to $(1.3) million in the same quarter of the previous fiscal year [5]. - Adjusted EBITDA was $(1.2) million for the quarter, compared to $(1.0) million in the same quarter of the previous fiscal year [5]. Recent Developments - The company accepted a $700,000 product development order for an advanced augmented reality system and a $678,000 agreement for a high-end borescope for jet engines [5]. - Increased production to meet demand from a top-tier aerospace company, generating $2.5 million in revenue from this customer [5]. - Introduced a second production line for single-use endoscope assemblies, resulting in $1.6 million in revenue from a leading surgical company [5]. Financial Guidance - The company projects FY 2026 revenue to exceed $25 million, indicating a 31% growth over FY 2025 revenue [5]. - Projected Adjusted EBITDA for FY 2026 is approximately $0.5 million, a significant improvement from $(3.7) million in FY 2025 [5].

Core Viewpoint - Precision Optics Corporation will participate in the Lytham Partners Fall 2025 Investor Conference, hosting a webcast presentation and one-on-one meetings with investors on September 30, 2025 [1][2][3]. Company Overview - Precision Optics Corporation, founded in 1982, is a vertically integrated optics company focused on advanced optical instruments for the medical and defense/aerospace industries [4]. - The company leverages proprietary micro-optics, 3D imaging, and digital imaging technologies to provide services from product concept to mass manufacture [4]. - Precision Optics supports next-generation medical device companies by providing enhanced imaging systems for minimally invasive surgery and 3D endoscopy systems [4]. - The company has a long history of supplying optical products, including complex endocouplers and specialized endoscopes, to top-tier medical device companies [4]. - In the defense/aerospace sector, Precision Optics applies its technical proficiency in micro-optics to meet high-quality standards while optimizing size, weight, and power [4].

Core Insights - Precision Optics Corporation reported a record quarterly revenue of $6.2 million for Q4 2025, representing a 31% increase year-over-year, driven by strong demand from aerospace and surgical robotics sectors [6][7] - The company anticipates fiscal year 2026 revenue to exceed $25 million, indicating over 30% growth compared to fiscal year 2025 [6][8] - The appointment of Joseph Traut as the new Chief Operating Officer is expected to enhance operational efficiency and production capacity [9][10] Financial Highlights for Q4 2025 - Quarterly revenue reached $6.2 million, up from $4.7 million in Q4 2024, marking a growth of approximately 31% [6][7] - Production revenue was $5.1 million, a 54% increase from $2.8 million in the same quarter last year [7] - Gross margins decreased to 13.0% from 21.7% in the same quarter of the previous fiscal year [7] Financial Highlights for FY 2025 - Total revenue for FY 2025 was $19.1 million, consistent with the previous fiscal year [7][24] - Production revenue increased by 34% to $14.2 million compared to $10.6 million in FY 2024 [7] - The net loss for FY 2025 was $(5.8) million, compared to $(3.0) million in FY 2024 [7][24] FY 2026 Financial Guidance - The company projects FY 2026 revenue to exceed $25 million, representing a growth of approximately 31% over FY 2025 [6][8] - Expected gross margin for FY 2026 is approximately 30%, an improvement from 18% in FY 2025 [7][8] - Projected Adjusted EBITDA for FY 2026 is approximately $0.5 million, compared to $(3.7) million in FY 2025 [7][8] Operational Challenges and Improvements - Margins were impacted by production yields, staffing, and efficiency challenges, along with unexpected tariff costs [8] - The company has renegotiated pricing agreements to address yield shortfalls and anticipates improvements in gross margins throughout FY 2026 [8] - New product development initiatives are expected to enhance the utilization of engineering resources [8] Leadership Changes - Joseph Traut has been appointed as the new Chief Operating Officer, effective October 1, 2025, bringing extensive experience in operations management within the medical device sector [9][10] - The company expects Traut's expertise to contribute significantly to scaling operations and improving manufacturing efficiency [10]

Core Insights - Precision Optics Corporation will participate in the Lytham Partners 2025 Consumer & Technology Investor Summit on August 19, 2025 [1][2] - The company specializes in advanced optical instruments for the medical and defense/aerospace industries, leveraging proprietary technologies [3] Company Overview - Founded in 1982, Precision Optics is a vertically integrated optics company focused on micro-optics, 3D imaging, and digital imaging technologies [3] - The company provides services from product concept to mass manufacture, utilizing in-house design, prototype, regulatory, and fabrication capabilities [3] - In healthcare, Precision Optics supports the demand for enhanced imaging systems for minimally invasive surgery and 3D endoscopy systems [3] - The company has a long history of supplying optical products, including complex endocouplers and specialized endoscopes, to top-tier medical device companies [3] - In defense/aerospace, Precision Optics applies its micro-optics expertise to meet high-quality standards and optimize size, weight, and power [3]

Core Viewpoint - Precision Optics Corporation is set to announce its third quarter fiscal year 2025 financial results on May 15, 2025, followed by a conference call to discuss these results [1][2]. Company Overview - Precision Optics Corporation, founded in 1982, specializes in advanced optical instruments for the medical and defense/aerospace industries, focusing on micro-optics, 3D imaging, and digital imaging technologies [5]. - The company provides comprehensive services from product concept to mass manufacturing, leveraging in-house design, regulatory, and fabrication capabilities [5]. - In healthcare, Precision Optics supports the development of enhanced imaging systems for minimally invasive surgeries and 3D endoscopy systems, catering to the needs of surgical robotic systems [5]. - The company also applies its micro-optics expertise to defense/aerospace applications, emphasizing high quality and optimization of size, weight, and power [5]. Conference Call Details - The conference call is scheduled for May 15, 2025, at 5:00 p.m. ET, with access available via phone or live webcast [3]. - Call-in numbers include (844) 735-3662 or (412) 317-5705, and the webcast can be accessed at https://app.webinar.net/XMqWYwq1mQa [3]. - A replay of the call will be available for seven days, with specific access numbers and a replay code provided [4].